Health and Human Services Secretary Robert F. Kennedy Jr. is citing a complex statute to defend his department against conservative pushback against the Food and Drug Administration’s approval of a new abortion pill, saying that the agency’s hands are tied by the law when approving generics.
President Donald Trump’s health appointees drew ire from anti-abortion Republicans this week because the FDA, under Commissioner Marty Makary, approved a second generic version of the abortifacient mifepristone, which is used in nearly two-thirds of all abortions in the United States.
Kennedy said Thursday evening on X that the FDA “only approved a second generic mifepristone tablet because federal law requires approval when an application proves the generic is identical to the brand-name drug.”
Trending: House Speaker Mike Johnson Claims President Trump Is “Unwell”
But anti-abortion Republicans lambasted Kennedy and
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!